<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02036736</url>
  </required_header>
  <id_info>
    <org_study_id>P120702</org_study_id>
    <secondary_id>2012-005270-61</secondary_id>
    <nct_id>NCT02036736</nct_id>
  </id_info>
  <brief_title>Evaluating the Influence of the Strategy Intraoperative Anesthetic (Desflurane Versus Propofol) on Cognitive and Psychomotor Functions in Output Post Interventional Room Monitoring - COGNIDES</brief_title>
  <acronym>Cognides</acronym>
  <official_title>Randomized Study Evaluating the Influence of the Strategy Intraoperative Anesthetic (Desflurane Versus Propofol) on Cognitive and Psychomotor Functions in Output Post Interventional Room Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The recovery of cognitive and psychomotor functions is best performed under anesthesia after
      desflurane when propofol in that obtaining a Aldrete score&gt; 8/10 output of the allowing SSPI.

      The principal objective is to compare the cognitive and psychomotor status of patients
      recovered an Aldrete score&gt; 8/10 according to the anesthetic agent (propofol or desflurane)
      using three tests (Stroop test, Digit Symbol Substitution task and a test of verbal memory
      (visual verbal learning test) made SSPI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The day before surgery, patients sign the consent and will be randomized. Then 3 tests
      (Stroop test, Digit Symbol Substitution Task and visual verbal learning test) will be
      performed. No anxiolysis will be given to the patient. The anesthetic induction will be with
      IV propofol (2-3 mg / kg). The maintenance will anesthetic, desflurane by for a minimum
      alveolar concentration of between 2% and 6% or propofol for intravenous anesthesia user
      target controlled. In SSPI, the Aldrete score will be evaluated every 5min. Upon obtaining a
      Aldrete score&gt; 8/10, the day before the tests will be carried out again
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the cognitive and psychomotor status of patients recovered an Aldrete score&gt; 8/10 according to the anesthetic agent (propofol or desflurane)</measure>
    <time_frame>1 day</time_frame>
    <description>Compare the cognitive and psychomotor status of patients recovered an Aldrete score&gt; 8/10 according to the anesthetic agent (propofol or desflurane), using three tests (Stroop test, Digit Symbol Substitution Task and test verbal memory (visual verbal learning test) made room post-interventional monitoring
The primary endpoint will be the average score of three tests in room post-interventional monitoring (Stroop test, Digit Symbol Substitution Task, Visual Verbal Learning Test) scores expressed in standard deviation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>proportion of patients with nausea and vomiting</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Search intraoperative factors alterations in cognitive and psychomotor functions (number of red blood cells transfused, number of hypotensive episodes (≤ 80mmHg or MAP NOT ≤ 65mmHg)≥ 10 minutes).</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate patient satisfaction on a visual analogue scale in room post-interventional monitoring</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate postoperative pain in room post-interventional monitoring</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Orthopedic Surgery</condition>
  <condition>Total Hip Prosthesis</condition>
  <condition>Total Knee Replacement</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative anesthetic strategy by Propofol versus Desflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Desflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative anesthetic strategy by Desflurane versus Propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intraoperative anesthetic strategy by Propofol</intervention_name>
    <description>1- Arm Propofol: Propofol TCI induction target between 2 and 6 mg / mL
Sufentanil (0.15 mg / kg intravenously (IV))
Atracurium (0.5 mg / kg IV) Maintenance mode by Propofol TCI target between 2 and 4 micrograms / mL tune to 40 &lt;BIS &lt;60 Sufentanil bolus according to intraoperative analgesia Atracurium bolus according to the level of neuromuscular blockade</description>
    <arm_group_label>Desflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intraoperative anesthetic strategy by Desflurane</intervention_name>
    <description>2- Arm Desflurane Desflurane induction (2-3 mg / kg)
Sufentanil (0.15 mg / kg IV)
Atracurium (0.5 mg / kg IV)) Desflurane closed by maintenance target with minimal alveolar concentration (MAC) to adapt the circuit to obtain a figure 40 &lt;BIS &lt;60 Sufentanil bolus according to intraoperative analgesia Atracurium bolus according to the level of neuromuscular blockade</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years and ≤ 80 years

          -  ASA I, II

          -  General anesthesia provided

          -  Scheduled orthopedic surgery

          -  Duration of surgery between one and three hours

          -  Patient has given its written consent

          -  Patient receiving medical health insurance

        Exclusion Criteria:

          -  MMS (Mini Mental State) ≤ 24

          -  Patient does not speak or read or do not understand the French

          -  Previous surgery within seven days

          -  Coronary insufficiency, renal, hepatic

          -  Chronic pulmonary disease

          -  Obesity (BMI&gt; 35)

          -  Addiction

          -  Chronic alcoholism

          -  Hematocrit &lt;25%

          -  Personal and family history of malignant hyperthermia

          -  Taking benzodiazepines or psychotropic within 24 hours preoperative

          -  Psychiatric pathology being

          -  Psychological or neurological disorder causing difficulties in understanding the study

          -  Chronic pain and / or taking analgesics 3.

          -  Pregnancy or breastfeeding

          -  Disorder of hemostasis: platelets &lt;80,000 / mm3, PT &lt;50% TCA&gt; 1.5 times the control.

          -  Hypersensitivity to propofol or desflurane or any of the excipients

          -  Patients allergic to soy and peanuts

          -  History of liver disease, jaundice, unexplained fever, eosinophilia after
             administration of a halogenated anesthetic

          -  Hypersensitivity to egg lecithin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cyrille Robert, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2014</study_first_submitted>
  <study_first_submitted_qc>January 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2014</study_first_posted>
  <last_update_submitted>December 19, 2014</last_update_submitted>
  <last_update_submitted_qc>December 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Orthopedic Surgery</keyword>
  <keyword>Total hip prosthesis</keyword>
  <keyword>Total knee replacement</keyword>
  <keyword>Intraoperative anesthetic strategy</keyword>
  <keyword>Propofol</keyword>
  <keyword>Desflurane</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

